يعرض 1 - 10 نتائج من 214 نتيجة بحث عن '"major risk factor"', وقت الاستعلام: 0.83s تنقيح النتائج
  1. 1
  2. 2
    دورية أكاديمية
  3. 3
    كتاب إلكتروني

    المساهمون: Schlag, P. M., editorAff1, Senn, H.-J., editorAff2, Diehl, V., editorAff3, Parkin, D. M., editorAff4, Rajewsky, M. F., editorAff5, Rubens, R., editorAff6, Wannenmacher, M., editorAff7, Rentchnik, P., editorAff8, Oertel, Stephan H., editorAff9, Riess, Hanno, editorAff9

    المصدر: Immunosurveillance, Immunodeficiencies and Lymphoproliferations : Lymphoproliferative Disorders in Congenital and Acquired Immunodeficiencies. 159:55-66

  4. 4
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

  5. 5
    دورية أكاديمية
  6. 6

    المساهمون: Carrizzo, A., Moltedo, O., Damato, A., Martinello, K., Di Pietro, P., Oliveti, M., Acernese, F., Giugliano, G., Izzo, R., Sommella, E., Migliarino, S., Piazza, O., Izzo, C., Virtuoso, N., Strianese, A., Trimarco, V., Campiglia, P., Fucile, S., Puca, A., Trimarco, B., Vecchione, C.

    المصدر: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

    مصطلحات موضوعية: Male, AkP05 reduced BP and improved endothelial function, Disease, 030204 cardiovascular system & hematology, Camellia sinensis, chemistry.chemical_compound, and end-organ damage. However, Mice, 0302 clinical medicine, endothelial function, cardiovascular disease, Medicine, Stroke, Original Research, 0303 health sciences, Exercise Tolerance, and circulating nitric oxide were assessed before and at the end of 4 weeks of treatment. Twenty-four patients were randomized to diuretic or AkP05 for 4 weeks and underwent a cardiopulmonary exercise test to evaluate the effects of AkP05 on functional capacity of the cardiovascular, Exercise capacity, Middle Aged, Background-—High blood pressure (BP) has long been recognized as a major health threat and, exercise capacity, and muscular systems. Vascular and molecular studies were undertaken on mice to characterize the action of the single compounds contained in the AkP05 nutraceutical combination. AkP05 supplementation reduced BP, cardiopulmonary exercise test revealed that AkP05 increased maximum O2 uptake, Hypertension, Cardiology, Female, Background-—High blood pressure (BP) has long been recognized as a major health threat and, particularly, a major risk factor for stroke, cardiovascular disease, and end-organ damage. However, the identification of a novel, alternative, integrative approach for the control of BP and cardiovascular protection is still needed. Methods and Results-—Sixty-nine uncontrolled hypertension patients, aged 40 to 68 years, on antihypertensive medication were enrolled in 2 double-blind studies. Forty-five were randomized to placebo or a new nutraceutical combination named AkP05, and BP, endothelial function, and circulating nitric oxide were assessed before and at the end of 4 weeks of treatment. Twenty-four patients were randomized to diuretic or AkP05 for 4 weeks and underwent a cardiopulmonary exercise test to evaluate the effects of AkP05 on functional capacity of the cardiovascular, pulmonary, and muscular systems. Vascular and molecular studies were undertaken on mice to characterize the action of the single compounds contained in the AkP05 nutraceutical combination. AkP05 supplementation reduced BP, improved endothelial function, and increased nitric oxide release, cardiopulmonary exercise test revealed that AkP05 increased maximum O2 uptake, stress tolerance, and maximal power output. In mice, AkP05 reduced BP and improved endothelial function, evoking increased nitric oxide release through the PKCa/Akt/endothelial nitric oxide synthase pathway and reducing reactive oxygen species production via NADPH-oxidase inhibition. These effects were mediated by synergism of the single compounds of AkP05. Conclusions-—This is the first study reporting positive effects of a nutraceutical combination on the vasculature and exercise tolerance in treated hypertensive patients. Our findings suggest that AkP05 may be used as an adjunct for the improvement of cardiovascular protection and to better control BP in uncontrolled hypertension, Cardiology and Cardiovascular Medicine, evoking increased nitric oxide release through the PKCa/Akt/endothelial nitric oxide synthase pathway and reducing reactive oxygen species production via NADPH-oxidase inhibition. These effects were mediated by synergism of the single compounds of AkP05. Conclusions-—This is the first study reporting positive effects of a nutraceutical combination on the vasculature and exercise tolerance in treated hypertensive patients. Our findings suggest that AkP05 may be used as an adjunct for the improvement of cardiovascular protection and to better control BP in uncontrolled hypertension, integrative approach for the control of BP and cardiovascular protection is still needed. Methods and Results-—Sixty-nine uncontrolled hypertension patients, particularly, alternative, Adult, medicine.medical_specialty, pulmonary, on antihypertensive medication were enrolled in 2 double-blind studies. Forty-five were randomized to placebo or a new nutraceutical combination named AkP05, Phosphatidylserines, Nitric Oxide, Nitric oxide, 03 medical and health sciences, Nutraceutical, Double-Blind Method, Internal medicine, Animals, Humans, a major risk factor for stroke, and BP, Risk factor, aged 40 to 68 years, and maximal power output. In mice, 030304 developmental biology, Aged, stress tolerance, business.industry, Mechanism (biology), and increased nitric oxide release, Ginkgo biloba, vascular biology, medicine.disease, nitric oxide, improved endothelial function, Blood pressure, chemistry, Dietary Supplements, Exercise Test, Bacopa, Plant Preparations, the identification of a novel, business, Reactive Oxygen Species, Phytotherapy

  7. 7
  8. 8
    دورية أكاديمية
  9. 9
    كتاب إلكتروني

    المؤلفون: Ames, B. N.Aff5, Hagen, T. M.Aff5, Shigenaga, M. K.Aff5

    المساهمون: Nigam, Santosh, editorAff1, Honn, Kenneth V., editorAff2, Marnett, Lawrence J., editorAff3, Walden, Thomas L., Jr., editorAff4

    المصدر: Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Radiation Injury : Proceedings of the 2nd International Conference September 17–21, 1991 Berlin, FRG. 71:383-385

  10. 10
    كتاب إلكتروني

    المؤلفون: Roy, C.Aff1_64, Roque, J. L.Aff1_64, Francois, P. M.Aff1_64, Ferrieres, A.Aff1_64, Raboisson, D.Aff2_64

    المساهمون: Hogeveen, H., editorAff1, Lam, T. J. G. M., editorAff1

    المصدر: Udder Health and Communication. :346-346